Trials / Completed
CompletedNCT02790281
A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to measure IL-6 and IL-6/sIL-6R complex levels in subjects with active moderate to severe ulcerative colitis or Crohn's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood sampling | Blood sample collected at a single visit |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2016-06-03
- Last updated
- 2017-03-06
- Results posted
- 2017-03-06
Locations
2 sites across 2 countries: Denmark, Sweden
Source: ClinicalTrials.gov record NCT02790281. Inclusion in this directory is not an endorsement.